stockportfolio.pro
Cytek Biosciences, Inc. Shares Outstanding 2020–2025
Cytek Biosciences, Inc. (CTKB) annual shares outstanding by fiscal year, computed from SEC filings. Compound growth +32.7%/yr over 5 years.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 128.6M | -0.5% |
| FY 2024 | 129.2M | -1.2% |
| FY 2023 | 130.7M | -3.4% |
| FY 2022 | 135.4M | +1.2% |
| FY 2021 | 133.7M | +328.1% |
| FY 2020 | 31.2M | — |
Source: Cytek Biosciences, Inc. SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Cytek Biosciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCytek Biosciences, Inc. — frequently asked questions
What is Cytek Biosciences, Inc.'s shares outstanding?
Cytek Biosciences, Inc. (CTKB) reported shares outstanding of 128.6M for fiscal year 2025, per its SEC filings.
How has Cytek Biosciences, Inc.'s shares outstanding changed over time?
Between fiscal 2020 and 2025, CTKB's shares outstanding grew at roughly 32.7% per year (compound annual rate), from 31.2M to 128.6M.
Where does this data come from?
Figures are computed from Cytek Biosciences, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.